Glucocorticoids and 11 β-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney

European Journal of Clinical Investigation

Volumn 32, Issue 6, 2002, Pages 411-420

  Audige A ^a   Dick, B ^a   Frey, B M ^a   Frey, F J ^a   Corman, B ^b   Vogt, Bruno ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Service de Biologie Cellulaire   (France)

Author keywords

11 HSD; Aging; Gene expression; Glucocorticoids; Progesterone

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID; MESSENGER RNA; SODIUM;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DNA MICROARRAY; ENZYME ACTIVITY; KIDNEY; KIDNEY MICROSOME; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; URINARY EXCRETION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGING; ANIMALS; ELECTROLYTES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; KIDNEY; MALE; MICROSOMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED STRAINS;

EID: 0037000535     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01003.x     Document Type: Article

References (69)

1. Angeli A, Masera RG, Magri F, Ferrari E. The adrenal cortex in physiological and pathological aging: issues of clinical relevance. J Endocrinol Invest 1999;22:13-8.
2. Seckl JR. Glucocorticoids, ageing and nerve cell damage. J Neuroendocrinol 2000;12:709-10.
3. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994;105:R11-7.
4. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 1989;264:18939-43.
5. Krozowski Z, Li KX, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A et al. The type I and type II 11β-hydroxysteroid dehydrogenase enzymes. J Steroid Biochem Mol Biol 1999;69:391-401.
6. Stewart PM, Krozowski ZS. 11β-Hydroxysteroid dehydrogenase. Vitam Horm 1999;57:249-324.
7. Odermatt A, Arnold P, Stauffer A, Frey BM, Frey FJ. The N-terminal anchor sequences of 11β-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J Biol Chem 1999;274:28762-70.
8. Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ. Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle. J Exp Med 1997;186:189-98.
9. White PC, Mune T, Agarwal AK. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135-56.
10. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;2:821-4.
11. Jamieson PM, Chapman KE, Seckl JR. Tissue- and temporal-specific regulation of 11β-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. J Steroid Biochem Mol Biol 1999;68:245-50.
12. Igarreta P, Calvo JC, Damasco MC. Activity of renal 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) in stressed animals. Life Sci 1999;64:2285-90.
13. Nwe KH, Norhazlina AW, Hamid A, Morat PB, Khalid BA. In vivo effects of stress, ACTH and corticosterone on testicular 11β-hydroxysteroid dehydrogenase oxidative activity in rats and the possible mechanism of actions. Exp Clin Endocrinol Diabetes 2000;108:369-77.
14. Darnel AD, Archer TK, Yang K. Regulation of 11β-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line. J Steroid Biochem Mol Biol 1999;70:203-10.
15. Landfield PW, Waymire JC, Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 1978;202:1098-102.
16. Sapolsky RM, Krey LC, McEwen BS. The adrenocortical stress-response in the aged male rat: impairment of recovery from stress. Exp Gerontol 1983;18:55-64.
17. DeKosky ST, Scheff SW, Cotman CW. Elevated corticosterone levels. A possible cause of reduced axon sprouting in aged animals. Neuroendocrinology 1984;38:33-8.
18. Oxenkrug GF, McIntyre IM, Gershon S. Effects of pinealectomy and aging on the serum corticosterone circadian rhythm in rats. J Pineal Res 1984;1:181-5.
19. Scaccianoce S, Di Sciullo A, Angelucci L. Age-related changes in hypothalamo-pituitary-adrenocortical axis activity in the rat. In vitro studies. Neuroendocrinology 1990;52:150-5.
20. Meaney MJ, Aitken DH, Sharma S, Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and age-related changes in hippocampal type I and type II corticosteroid receptor binding capacity in young and aged, handled and nonhandled rats. Neuroendocrinology 1992;55:204-13.
21. Kizaki T, Ookawara T, Iwabuchi K, Onoe K, Day NK, Good RA et al. Age-associated increase of basal corticosterone levels decreases ED2high, NF-kappaB high activated macrophages. J Leukoc Biol 2000;68:21-30.
22. Hess GD, Riegle GD. Adrenocortical responsiveness to stress and ACTH in aging rats. J Gerontol 1970;25:354-8.
23. Britton GW, Rotenberg S, Freeman C, Britton VJ, Karoly K, Ceci L et al. Regulation of corticosterone levels and liver enzyme activity in aging rats. Adv Exp Med Biol 1975;61:209-28.
24. Tang F, Phillips JG. Some age-related changes in pituitary-adrenal function in the male laboratory rat. J Gerontol 1978;33:377-82.
25. Brett LP, Chong GS, Coyle S, Levine S. The pituitary-adrenal response to novel stimulation and ether stress in young adult and aged rats. Neurobiol Aging 1983;4:133-8.
26. Sonntag WE, Goliszek AG, Brodish A, Eldridge JC. Diminished diurnal secretion of adrenocorticotropin (ACTH), but not corticosterone, in old male rats: possible relation to increased adrenal sensitivity to ACTH in vivo. Endocrinology 1987;120:2308-15.
27. Ferrini M, Piroli G, Frontera M, Falbo A, Lima A, De Nicola AF. Estrogens normalize the hypothalamic-pituitary-adrenal axis response to stress and increase glucocorticoid receptor immuno-reactivity in hippocampus of aging male rats. Neuroendocrinology 1999;69:129-37.
28. Lupo-di Prisco C, Dessi-Fulgheri F. Endocrine and behavioral modifications in aging male rats. Horm Res 1980;12:149-60.
29. Carnes M, Goodman BM, Lent SJ, Vo H, Jaeckels R. Coincident plasma ACTH and corticosterone time series: comparisons between young and old rats. Exp Gerontol 1994;29:625-43.
30. Cizza G, Calogero AE, Brady LS, Bagdy G, Bergamini E, Blackman MR et al. Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology 1994;134:1611-20.
31. Gruenewald DA, Naai MA, Marck BT, Matsumoto AM. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat. J Androl 2000;21:72-84.
32. Sapolsky RM. Do glucocorticoid concentrations rise with age in the rat? Neurobiol Aging 1992;13:171-4.
33. van Eekelen JA, Rots NY, Sutanto W, de Kloet ER. The effect of aging on stress responsiveness and central corticosteroid receptors in the brown Norway rat. Neurobiol Aging 1992;13:159-70.
34. Wang PS, Lo MJ, Kau MM. Glucocorticoids and aging. J Formos Med Assoc 1997;96:792-801.
35. Corman B, Pratz J, Poujeol P. Changes in anatomy, glomerular filtration, and solute excretion in aging rat kidney. Am J Physiol 1985;248:R282-7.
36. Corman B, Michel JB. Glomerular filtration, renal blood flow, and solute excretion in conscious aging rats. Am J Physiol 1987;253:R555-60.
37. Corman B, Roinel N. Single-nephron filtration rate and proximal reabsorption in aging rats. Am J Physiol 1991;260:F75-80.
38. Michel JB, Heudes D, Michel O, Poitevin P, Philippe M, Scalbert E et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol 1994;267:R124-35.
39. + retention. Steroids 1994;59:352-6.
40. Souness GW, Latif SA, Laurenzo JL, Morris DJ. 11α- and 11β-hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocrinology 1995;136:1809-12.
41. Souness GW, Morris DJ. 11α- and 11β-hydroxyprogesterone, potent inhibitors of 11β-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat. Hypertension 1996;27:421-5.
42. + retention and hypertension. Endocr Res 1996;22:793-801.
43. Latif SA, Sheff MF, Ribeiro CE, Morris DJ. Selective inhibition of sheep kidney 11 beta-hydroxysteroid dehydrogenase isoform 2 activity by 5 α-reduced (but not 5 β) derivatives of adrenocorticosteroids. Steroids 1997;62:230-7.
44. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
45. Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN et al. A mutation in the cofactor-binding domain of 11β-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. J Clin Endocrinol Metab 2001;86:1247-52.
46. Escher G, Vogt B, Beck T, Guntern D, Frey BM, Frey FJ. Reduced 11β-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy. Endocrinology 1998;139:1533-9.
47. Preisser L, Teillet L, Aliotti S, Gobin R, Berthonaud V, Chevalier J et al. Downregulation of aquaporin-2 and -3 in aging kidney is independent of;V (2): vasopressin receptor. Am J Physiol Renal Physiol 2000;279:F144-52.
48. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 1987;43:113-73.
49. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-3.
50. Alfaidy N, Blot-Chabaud M, Bonvalet JP, Farman N. Vasopressin potentiates mineralocorticoid selectivity by stimulating 11β-hydroxysteroid deshydrogenase in rat collecting duct. J Clin Invest 1997;100:2437-42.
51. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 1996;45:605-11.
52. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol 1997;47:231-6.
53. Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH. Congenital deficiency of 11β-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone. J Endocrinol Invest 2001;24:17-23.
54. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 1989;257:E6-14.
55. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD. Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol. J Clin Endocrinol Metab 1989;68:1019-26.
56. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 1990;71:452-63.
57. Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD. Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 1998;139:443-50.
58. Windle RJ, Wood SA, Lightman SL, Ingram CD. The pulsatile characteristics of hypothalamo-pituitary-adrenal activity in female Lewis and Fischer 344 rats and its relationship to differential stress responses. Endocrinology 1998;139:4044-52.
59. Lightman SL, Windle RJ, Julian MD, Harbuz MS, Shanks N, Wood SA et al. Significance of pulsatility in the HPA axis. Novartis Found Symp 2000;227:244-57.
60. Stewart PM, Shackleton CH, Beastall GH, Edwards CR. 5 alpha-reductase activity in polycystic ovary syndrome. Lancet 1990;335:431-3.
61. Luppa P, Muller B, Jacob K, Kimmig R, Strowitzki T, Hoss C et al. Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion. J Clin Endocrinol Metab 1995;80:280-8.
62. Chin D, Shackleton C, Prasad VK, Kohn B, David R, Imperato-McGinley J et al. Increased 5alpha-reductase and normal 11β-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2000;13:253-9.
63. Raven PW, Taylor NF. Evidence for independent modulation of human 11-HSD and 5α/5β reductase activities. Endocr Res 1996;22:811-5.
64. Simpkins JW, Kalra PS, Kalra SP. Alterations in daily rhythms of testosterone and progesterone in old male rats. Exp Aging Res 1981;7:25-32.
65. Amador A, Steger RW, Bartke A, Johns A, Siler-Khodr TM, Parker CR et al. Testicular LH receptors during aging in Fisher 344 rats. J Androl 1985;6:61-4.
66. Gruenewald DA, Hess DL, Wilkinson CW, Matsumoto AM. Excessive testicular progesterone secretion in aged male Fischer 344 rats: a potential cause of age-related gonadotropin suppression and confounding variable in aging studies. J Gerontol 1992;47:B164-70.
67. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA et al. Synthesis of corticosterone in the vascular wall. Endocrinology 1994;135:2283-6.
68. Levine LS, Rauh W, Gottesdiener K, Chow D, Gunczler P, Rapaport R et al. New studies of the 11β-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1980;50:258-63.
69. Chapman TE, Kraan GP, Nagel GT, Wolthers BG, Drayer NM. Measurement of the cortisol production rate in two sisters with 17α-hydroxylase deficiency using [1,2,3,4-13C]cortisol and isotope dilution mass spectrometry. J Steroid Biochem Mol Biol 1991;38:489-96.